CareRx Declares Q4 2025 Dividend, Reinforcing Shareholder Value

CareRx ( (TSE:CRRX) ) has provided an announcement.

CareRx Corporation has announced a dividend of CAD$0.02 per common share, payable on January 21, 2026, to shareholders of record as of December 23, 2025. This move underscores CareRx’s commitment to delivering value to its shareholders while maintaining its leadership position in the pharmacy services sector for senior living communities across Canada.

The most recent analyst rating on (TSE:CRRX) stock is a Hold with a C$3.50 price target. To see the full list of analyst forecasts on CareRx stock, see the TSE:CRRX Stock Forecast page.

Spark’s Take on TSE:CRRX Stock

According to Spark, TipRanks’ AI Analyst, TSE:CRRX is a Neutral.

CareRx’s overall stock score is driven by a strong earnings call performance, highlighting revenue and EBITDA growth, positive net income, and reduced debt. However, financial performance is hindered by negative net margins and high reliance on debt. Technical indicators suggest a neutral trend, while the valuation appears stretched with a high P/E ratio. The dividend initiation provides a positive signal of financial confidence.

To see Spark’s full report on TSE:CRRX stock, click here.

More about CareRx

CareRx is Canada’s leading provider of pharmacy services to seniors living and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company operates a national network of pharmacy fulfillment centers, utilizing advanced technology to ensure timely, cost-effective delivery and high safety standards in medication management.

Average Trading Volume: 36,619

Technical Sentiment Signal: Buy

Current Market Cap: C$233.5M

See more data about CRRX stock on TipRanks’ Stock Analysis page.